Larvol Delta - Generation-of-a-panel-of-mutants-that-are-resistant-to-standard-of-care-therapies-in-a-clinically-relevant-strain-of-Human-cytomegalovirus-for-drug-resistance-profiling

Vistide (cidofovir) - Gilead

Cytovene (ganciclovir) - Roche

Prevymis (letermovir) - Merck (MSD)

Livtencity (maribavir) - Takeda, GSK

http://www.ncbi.nlm.nih.gov/pubmed/40653174

Eain A Murphy; Kassidy Knight; Meghan F Carter; Yetunde Kayode

Jul 14, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next